CTRI Number |
CTRI/2023/05/052811 [Registered on: 17/05/2023] Trial Registered Prospectively |
Last Modified On: |
17/05/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia Other (Specify) [Neuromuscular monitoring device ] |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Comparison of intubating conditions of two drugs using train of four neuromuscular monitoring by stimulating ulnar nerve with submaximal current 10-15mA |
Scientific Title of Study
|
Randomized Prospective Study to Compare Intubating conditions with Cisatracurium or Rocuronium using train of Four Neuromuscular Monitoring in Adult Patients Undergoing Elective Surgery |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Vipin Kumar Dhama |
Designation |
Professor |
Affiliation |
LLRM Medical college Meerut |
Address |
Department of Anaesthesiology LLRM Medical College meerut
Meerut UTTAR PRADESH 250004 India |
Phone |
9760014177 |
Fax |
|
Email |
drvipindhama@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Vipin Kumar Dhama |
Designation |
Professor |
Affiliation |
LLRM Medical college Meerut |
Address |
Department of Anaesthesiology LLRM Medical College meerut
Meerut UTTAR PRADESH 250004 India |
Phone |
9760014177 |
Fax |
|
Email |
drvipindhama@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Radhika kukreja |
Designation |
Junior resident |
Affiliation |
LLRM Medical college Meerut |
Address |
Department of Anaesthesiology LLRM Medical College meerut
Meerut UTTAR PRADESH 250004 India |
Phone |
7696861470 |
Fax |
|
Email |
drkukrejafk@gmail.com |
|
Source of Monetary or Material Support
|
Department of Anaesthesiology LLRM Medical College meerut |
|
Primary Sponsor
|
Name |
Dr vipin kumar dhama |
Address |
Department of anaesthesiology LLRM MEDICAL COLLEGE MEERUT |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Vipin Kumar Dhama |
LLRM medical College |
Department of anesthesiology surgery operation theatre block 1st floor Meerut UTTAR PRADESH |
9760014177
drvipindhama@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
The Institutional Ethics Committee LLRM Medical College meerut |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
CISATRACURIUM |
Comparison of intubating conditions with train of four neuromuscular monitoring with LOADING DOSE-0.15mg/kg
MAINTAINENCE DOSE-0.03mg/kg |
Comparator Agent |
ROCURONIUM |
LOADING DOSE -0.6mg/kg
MAINTAINENCE DOSE -0.2mg/kg |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
ASA grade I and grade II Patients
Patients undergoing elective surgery |
|
ExclusionCriteria |
Details |
Patient refusal
Pregnancy
Coagulopathy
Anticipated Difficult airway
Any severe systemic disease |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
On-site computer system |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To evaluate intubating conditions using train of four neuromuscular monitoring with cisatracurium or rocuronium |
40min |
|
Secondary Outcome
|
Outcome |
TimePoints |
To compare systemic effect of cisatracurium or rocuronium on hemodynamic parameters |
30min |
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
01/06/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [drkukrejafk@gmail.com ].
- For how long will this data be available start date provided 12-04-2024 and end date provided 16-09-2024?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
Research clinical trial entitled "Randomized Prospective Study to Compare Intubating conditions with Cisatracurium or Rocuronium using train of Four Neuromuscular Monitoring in Adult Patient Undergoing Elective Surgery " will enlist 80 patients admitted to SVBP Hospital associated to LLRM Medical College meerut Undergoing various elective surgeries after informed patient consent. The enlisted patients will be divided into two groups of 40 each and primary with secondary objectives will be observed and documented. |